Weston says that Johnson & Johnson asked too much in needleless deal
This article was originally published in Clinica
Executive Summary
Weston Medical says that it pulled out of an agreement with a Johnson & Johnson subsidiary to develop an unnamed drug, saying that the demands of the larger company could adversely affect the way that Weston develops its commercialisation plan.